Myeloid sarcoma and pathological fracture: a case report and review of literature

Springer Science and Business Media LLC - Tập 118 - Trang 745-750 - 2023
Sho Takeyasu1, Ken Morita1, Seitaro Saito1, Masanori Toho1, Takashi Oyama1, Takafumi Obo1, Kazuki Taoka1, Arika Shimura1, Hiroaki Maki1, Eisuke Shibata2, Yusuke Watanabe2, Fumio Suzuki2, Liuzhe Zhang3, Hiroshi Kobayashi3, Munetoshi Hinata4, Mineo Kurokawa1
1Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
2Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
3Department of Orthopedic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
4Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Tóm tắt

Myeloid sarcoma is a rare clinical entity that presents as an isolated proliferation of leukemic cells, concurrently with or at relapse of acute myeloid leukemia (AML), myelodysplastic syndromes/neoplasms (MDS), chronic myeloid leukemia (CML), and myeloproliferative neoplasm (MPN). Myeloid sarcoma disrupts the normal architecture of its surrounding tissues. When it forms in long bones, it can cause their pathological fracture. We recently experienced a rare case of MDS presenting with myeloid sarcoma in the femur that eventually resulted in its pathological fracture. Detailed chromosomal analysis of the bone marrow cells suggested emergence of myeloid sarcoma during the fast-paced progression of MDS just after acquiring trisomy 22. A comprehensive review of previous cases of myeloid sarcoma-associated pathological fracture indicated possible involvement of structural rearrangements of chromosomes 9 and 22. Management of myeloid sarcoma should continue to improve, and clinicians should note that myeloid sarcoma with specific chromosomal alterations needs extra medical attention to prevent pathological fracture.

Tài liệu tham khảo